Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

Professor

Pharmacy Clinical & Admin Sci

Phone (405) 271-6878 x47296

Office O'Donoghue Research Bldg., 1122 NE 13th St., Ste. 4417, OKC 73117

Email jamie-miller@ouhsc.edu


Publications & Presentations

    101. Boucher E A, Burke M M, Johnson P N, Klein K C, Miller J L. Minimum requirements for core competency in pediatric pharmacy practice. Journal of Pediatric Pharmacology and Therapeutics. 2015; 20 : 458-61

    102. Heard A N, Miller J L, Couloures K, Johnson P N. Non-intravenous sedatives for procedural sedation for imaging procedures in children. Journal of Pediatric Pharmacology and Therapeutics. 2015; 20 : 418-30

    103. Oldham M M, Burton M E, Johnson P N, Miller J L. "Once-daily" versus "extended-interval" administration of aminoglycosides in neonates: need for standard terminology. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2014; 71 : 2108-9

    104. Chandler C, Miller J L, Cunnyngham C, Johnson P N. Propylene-glycol induced lactic acidosis in a child receiving a pentobarbital continuous infusion. Journal of Pediatric Intensive Care. 2014; 3 : 73-77

    105. Lammers E M, Johnson P N, Ernst K D, Hagemann T M, Lawrence S M, Williams P K, Anderson M, Miller J L. Association of fentanyl with neurodevelopmental outcomes in very-low-birth-weight infants. The Annals of pharmacotherapy. 2014; 48 : 335-42




Grants

    1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

    2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

    3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

    4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

    5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.




Awards and Honors

<< 1 2 3 4 >>
                                                                                            6. University of Oklahoma Health Sciences Center. President's Associates Presidential Professorship. Date: 2023.  

                                                                                            7. Pediatric Pharmacy Association. Christensen Memorial Young Investigator Award Nominee (Resident Mentor). Date: 2022.  

                                                                                            8. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2019.  

                                                                                            9. Rho Chi, Gamma Chapter. 2019 Chapter Alumni Award. Date: 2019.  

                                                                                            10. Oklahoma Society of Health-System Pharmacists. Oklahoma Pharmacist of the Year. Date: 2019.  

<< 1 2 3 4 >>



Education

                                                                                            1.  Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.  

                                                                                            2.  Degree: BS. Trevecca Nazarene University. Date: 2002.  




Administrative Assignments

                                                

    1. Role: Department Vice-Chair. Scope: Department. Date: 2021.